Long-term efficacy of first-line versus second-line pegylated interferon in the treatment of essential thrombocythaemia and polycythaemia vera - results of a single-centre retrospective audit

被引：0
|
作者：
James, Daniel [1 ]
Verigou, Eleni-Anna [1 ]
Wilson, Andrew [2 ]
O'Nions, Jenny [2 ]
Ahmed, Syeda [2 ]
Alimam, Samah [3 ]
Sekhar, Mallika [2 ]
Lambert, Jonathan [2 ]
机构：
[1] UCL, Sch Med, London, England
[2] Univ Coll London Hosp NHS Fdn Trust, London, England
[3] Guys & St Thomas NHS Fdn Trust, London, England
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2021年 / 193卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
BSH2021-PO
引用
收藏
页码：113 / 113
页数：1
相关论文
共 50 条
  • [1] Use of pegylated interferon as second-line therapy in patients with essential thrombocythaemia or polycythaemia vera who are refractory or intolerant to other agents
    Rea, C. J.
    Radia, D. H.
    Cameron, L.
    Francis, Y.
    Harrison, C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2009, 145 : 66 - 66
  • [2] Results of Second-Line Chemotherapy in Pleural Mesothelioma: A Single-Centre, Retrospective Study
    Pardo Ruiz, Juan Carlos
    Garcia Garcia, Yolanda
    Ribera Fernandez, Paula
    Marin Alcala, Maria
    Ferrer Cardona, Marta
    Montero De Novoa, Helena Oliveres
    Martinez Vila, Clara
    Cabrera Romero, Jose Manuel
    Giner Joaquin, Julia
    Macias Declara, Ismael
    Dalmau Portulas, Elsa
    Saigi Grau, Eugeni
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1379 - S1380
  • [3] Final Results of Prospective Treatment with Pegylated Interferon Alfa-2a for Patients with Polycythemia Vera and Essential Thrombocythemia in First and Second-Line Settings
    Yacoub, Abdulraheem
    Mascarenhas, John
    Mesa, Ruben A.
    Kosiorek, Heidi E.
    Rampal, Raajit K.
    Silver, Richard T.
    Salama, Mohamed E.
    Siwoski, Olivia
    Dueck, Amylou C.
    Sandy, Lonette
    McMullin, Mary Frances
    Ewing, Joanne
    O'Connell, Casey L.
    Mead, Adam J.
    De Stefano, Valerio
    Weinberg, Rona Singer
    Baer, Maria R.
    Kessler, Craig M.
    Winton, Elliott F.
    Vannucchi, Alessandro M.
    Kremyanskaya, Marina
    Vadakara, Joseph
    Rosti, Vittorio
    Hexner, Elizabeth O.
    Rondelli, Damiano
    Arcasoy, Murat O.
    Rambaldi, Alessandro
    Ritchie, Ellen K.
    Barbui, Tiziano
    Kiladjian, Jean-Jacques
    Harrison, Claire N.
    Prchal, Josef T.
    Hoffman, Ronald
    BLOOD, 2019, 134
  • [4] A retrospective study on the efficacy of first-line and second-line therapies for acute graft-versus-host disease
    Sakellari, I
    Kartsios, H
    Kaloyannidis, P
    Smias, C
    Yannaki, E
    Batsis, I
    Sotiropoulos, D
    Anagnostopoulos, A
    Fassas, A
    Papanicolaou, G
    BONE MARROW TRANSPLANTATION, 2005, 35 : S326 - S326
  • [5] Chlormethine Gel Effectiveness as second-line Treatment in Mycosis fungoides: a single-centre Retrospective Study
    Zengarini, C.
    Vocale, L.
    Morsia, E.
    Mussi, M.
    Filippini, A.
    Piraccini, B. M.
    Pileri, A.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S19 - S19
  • [6] Compared Efficacy of Second-Line Treatments for Ulcerative Colitis After Failure of Vedolizumab in First-Line Treatment: A Retrospective Multicenter Study
    Calmejane, L.
    Reenaers, C.
    Amiot, A.
    Nuzzo, A.
    Vuitton, L.
    Altwegg, R.
    Guillo, L.
    Wils, P.
    Roblin, X.
    Le Cosquer, G.
    Simon, M.
    Benezech, A.
    Laharie, D.
    Fumery, M.
    Buisson, A.
    Charkaoui, M.
    Nancey, S.
    Sabra, G.
    Geyl, S.
    Coffin, B.
    Cavicchi, M.
    Le Berre, C.
    Goutorbe, F.
    Bouguen, G.
    Vidon, M.
    Christmann, P. Y.
    Kirchgesner, J.
    Uzzan, M.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I699 - I699
  • [7] Efficacy and HIV drug resistance profile of second-line ART among patients having received long-term first-line regimens in rural China
    Jing Wang
    Zhe Wang
    Jia Liu
    Yanchao Yue
    Shimei Yang
    Huimin Huang
    Cui He
    Lingjie Liao
    Hui Xing
    Yuhua Ruan
    Yiming Shao
    Scientific Reports, 5
  • [8] Efficacy and HIV drug resistance profile of second-line ART among patients having received long-term first-line regimens in rural China
    Wang, Jing
    Wang, Zhe
    Liu, Jia
    Yue, Yanchao
    Yang, Shimei
    Huang, Huimin
    He, Cui
    Liao, Lingjie
    Xing, Hui
    Ruan, Yuhua
    Shao, Yiming
    SCIENTIFIC REPORTS, 2015, 5
  • [9] The choice of second-line therapy in steroid-resistant immune thrombocytopenia: Role of platelet kinetics in a single-centre long-term study
    Palandri, Francesca
    Polverelli, Nicola
    Catani, Lucia
    Sollazzo, Daria
    Romano, Marco
    Levorato, Maurizio
    Vianelli, Nicola
    AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (11) : 1047 - 1050
  • [10] Efficacy of bevacizumab in second-line versus first-line treatment of metastatic colorectal cancer: Results from a new methodological approach based on the ITACa strategy trial.
    Petracci, Elisabetta
    Scarpi, Emanuela
    Passardi, Alessandro
    Frassineti, Giovanni Luca
    Biggeri, Annibale
    Amadori, Dino
    Nanni, Oriana
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345